Medical Management of Hemorrhagic Stroke

  • Jeong-Ho Hong
Part of the Stroke Revisited book series (STROREV)


Hemorrhagic stroke accounts for approximately 10–20% of all strokes and is the leading cause of disability and death in the world. Patients with hemorrhagic stroke are often accompanied by other organ failures, in particular lung and heart, at the time of presentation. In addition, neurological and medical emergencies that require intervention are complicated together with time-sensitive matters, which occur subsequent to the initial evaluation. Early neurologic deterioration often occurs in the early stage of brain injuries. These are the sufficient reasons why patients with hemorrhagic stroke should be taken care of in an intensive care unit or dedicated stroke unit with skilled physicians and trained nurses and monitored after diagnosis, and also, we have to learn the medical and neurocritical management for treating the patients with hemorrhagic stroke. This chapter is to describe the medical management principles of mainly two common subtypes of hemorrhagic stroke: spontaneous intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage.


  1. 1.
    Kim BJ, Lee SH. Cerebral microbleeds: their associated factors, radiologic findings, and clinical implications. J Stroke. 2013;15:153–63.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–37.CrossRefPubMedGoogle Scholar
  3. 3.
    Becker KJ, Baxter AB, Bybee HM, et al. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke. 1999;30:2025–32.CrossRefPubMedGoogle Scholar
  4. 4.
    Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Delgado Almandoz JE, Yoo AJ, Stone MJ, et al. Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score. Stroke. 2009;40:2994–3000.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hemphill JC III, Bonovich DC, Besmertis L, et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32:2012–20.CrossRefPubMedGoogle Scholar
  8. 8.
    Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59:21–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry. 1988;51:1457.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20.CrossRefPubMedGoogle Scholar
  11. 11.
    Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37.CrossRefPubMedGoogle Scholar
  12. 12.
    Li X, Sun Z, Zhao W, et al. Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage. J Neurosurg. 2013;118:94–103.CrossRefPubMedGoogle Scholar
  13. 13.
    Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387:2605–13.CrossRefPubMedGoogle Scholar
  14. 14.
    Frontera JA, Lewin JJ III, Rabinstein AA, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 2016;24:6–46.CrossRefPubMedGoogle Scholar
  15. 15.
    Kollmar R, Staykov D, Dorfler A, et al. Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke. 2010;41:1684–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Staykov D, Wagner I, Volbers B, et al. Mild prolonged hypothermia for large intracerebral hemorrhage. Neurocrit Care. 2013;18:178–83.CrossRefPubMedGoogle Scholar
  17. 17.
    Claassen J, Jette N, Chum F, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69:1356–65.CrossRefPubMedGoogle Scholar
  18. 18.
    Investigators N-SS, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.CrossRefGoogle Scholar
  19. 19.
    Australian N-SSIFT, New Zealand Intensive Care Society Clinical Trials Group, The Canadian Critical Care Trials Group, et al. Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study. Intensive Care Med. 2015;41:1037–47.CrossRefGoogle Scholar
  20. 20.
    Collaboration CT. Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial. Ann Intern Med. 2010;153:553–62.CrossRefGoogle Scholar
  21. 21.
    Collaboration CT, Dennis M, Sandercock P, et al. The effect of graduated compression stockings on long-term outcomes after stroke: the CLOTS trials 1 and 2. Stroke. 2013;44:1075–9.CrossRefGoogle Scholar
  22. 22.
    Collaboration CT, Dennis M, Sandercock PA, et al. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet. 2009;373:1958–65.CrossRefGoogle Scholar
  23. 23.
    Collaboration CT, Dennis M, Sandercock P, et al. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013;382:516–24.CrossRefGoogle Scholar
  24. 24.
    Paciaroni M, Agnelli G, Venti M, et al. Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-analysis of controlled studies. J Thromb Haemost. 2011;9:893–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Menon RS, Burgess RE, Wing JJ, et al. Predictors of highly prevalent brain ischemia in intracerebral hemorrhage. Ann Neurol. 2012;71:199–205.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Garg RK, Liebling SM, Maas MB, et al. Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke. 2012;43:67–71.CrossRefPubMedGoogle Scholar
  27. 27.
    Butcher KS, Jeerakathil T, Hill M, et al. The intracerebral hemorrhage acutely decreasing arterial pressure trial. Stroke. 2013;44:620–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004;43:18–24.CrossRefPubMedGoogle Scholar
  29. 29.
    Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Qureshi AI, Palesch YY, Martin R, et al. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch Neurol. 2010;67:570–6.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355–65.CrossRefPubMedGoogle Scholar
  32. 32.
    Qureshi AI, Palesch YY, Barsan WG, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375:1033–43.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Solenski NJ, Haley EC Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med. 1995;23:1007–17.CrossRefPubMedGoogle Scholar
  34. 34.
    Tanno Y, Homma M, Oinuma M, et al. Rebleeding from ruptured intracranial aneurysms in North Eastern Province of Japan. A cooperative study. J Neurol Sci. 2007;258:11–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke. 2001;32:1176–80.CrossRefPubMedGoogle Scholar
  36. 36.
    Hong JH, Bang JS, Chung JH, et al. Protocol based real-time continuous electroencephalography for detecting vasospasm in subarachnoid hemorrhage. J Korean Neurosurg Soc. 2016;59:154–7.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Barker FG II, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg. 1996;84:405–14.CrossRefPubMedGoogle Scholar
  38. 38.
    Vergouwen MD, Vermeulen M, Roos YB. Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review. Lancet Neurol. 2006;5:1029–32.CrossRefPubMedGoogle Scholar
  39. 39.
    Wartenberg KE, Schmidt JM, Mayer SA. Multimodality monitoring in neurocritical care. Crit Care Clin. 2007;23:507–38.CrossRefPubMedGoogle Scholar
  40. 40.
    Rose JC, Mayer SA. Optimizing blood pressure in neurological emergencies. Neurocrit Care. 2004;1:287–99.CrossRefPubMedGoogle Scholar
  41. 41.
    Hirzallah MI, Choi HA. The monitoring of brain edema and intracranial hypertension. J Neurocrit Care. 2016;9:92–104.CrossRefGoogle Scholar
  42. 42.
    Lundberg N. Continuous recording and control of ventricular fluid pressure in neurosurgical practice. Acta Psychiatr Scand Suppl. 1960;36:1–193.PubMedGoogle Scholar
  43. 43.
    Diringer MN, Zazulia AR. Osmotic therapy: fact and fiction. Neurocrit Care. 2004;1:219–33.CrossRefPubMedGoogle Scholar
  44. 44.
    Garcia-Morales EJ, Cariappa R, Parvin CA, et al. Osmole gap in neurologic-neurosurgical intensive care unit: its normal value, calculation, and relationship with mannitol serum concentrations. Crit Care Med. 2004;32:986–91.CrossRefPubMedGoogle Scholar
  45. 45.
    Suarez JI, Qureshi AI, Bhardwaj A, et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med. 1998;26:1118–22.CrossRefPubMedGoogle Scholar
  46. 46.
    Kamel H, Navi BB, Nakagawa K, et al. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med. 2011;39:554–9.CrossRefPubMedGoogle Scholar
  47. 47.
    Hays AN, Lazaridis C, Neyens R, et al. Osmotherapy: use among neurointensivists. Neurocrit Care. 2011;14:222–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg. 1991;75:731–9.CrossRefPubMedGoogle Scholar
  49. 49.
    Fischer M, Schiefecker A, Lackner P, et al. Targeted temperature management in spontaneous intracerebral hemorrhage: a systematic review. Curr Drug Targets. 2016;18(12):1430–40.Google Scholar
  50. 50.
    Choi HA, Ko SB, Presciutti M, et al. Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol. Neurocrit Care. 2011;14:389–94.CrossRefPubMedGoogle Scholar
  51. 51.
    Berkenstadt H, Margalit N, Hadani M, et al. Stroke volume variation as a predictor of fluid responsiveness in patients undergoing brain surgery. Anesth Analg. 2001;92:984–9.CrossRefPubMedGoogle Scholar
  52. 52.
    Charron C, Caille V, Jardin F, et al. Echocardiographic measurement of fluid responsiveness. Curr Opin Crit Care. 2006;12:249–54.CrossRefPubMedGoogle Scholar
  53. 53.
    Lyden PD, Shuaib A, Lees KR, et al. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT trial. Stroke. 2007;38:2262–9.CrossRefPubMedGoogle Scholar
  54. 54.
    Baumann A, Audibert G, Mcdonnell J, et al. Neurogenic pulmonary edema. Acta Anaesthesiol Scand. 2007;51:447–55.CrossRefPubMedGoogle Scholar
  55. 55.
    Lee VH, Connolly HM, Fulgham JR, et al. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg. 2006;105:264–70.CrossRefGoogle Scholar
  56. 56.
    Choi HA, Jeon SB, Samuel S, et al. Paroxysmal sympathetic hyperactivity after acute brain injury. Curr Neurol Neurosci Rep. 2013;13:370.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Singapore 2018

Authors and Affiliations

  • Jeong-Ho Hong
    • 1
  1. 1.Department of NeurologyKeimyung University Dongsan Medical CenterDaeguSouth Korea

Personalised recommendations